Abstract inhibition , protein kinase C * chick embryo cardiac myocytes To investigate how cardiac myocytes recover from a brief period of ischemia, we used a metabolic inhibition (MI) model, one of the in vitro ischemic models, of chick embryo ventricular myocytes, and examined the induction of immediate-early (TE) genes mRNAs and the activity of mitogenactivated protein (MAP) kinase. We performed Northern blot analysis to study the expression of c-jun, c-fos, and cmyc mRNAs during MI using 1 mM NaCN and 20 mM 2-deoxy-d-glucose, and also during the recovery from MI of 30 min. The c-fos mRNA was induced transiently at 30 and 60 min during the recovery. The expression of c-jun mRNA was significantly augmented at 30, 60, 90, and 120 min during the recovery (3.0-, 4.7-, 2.4-, and 1.9 -fold induction, respectively) and so did the expression of c-myc mRNA (1.4-, 1.7-, 1.8-, and 2.0-fold induction, respectively). In contrast, the levels of these mRNAs remained unchanged during MI. The electrophoretic mobility shift assay revealed that AP-1 DNA binding activity markedly increased at 120 mi during the recovery. When the cells were pretreated with protein kinase C (PKC) inhibitors, 100 IAM H-7 or 1 tIM staurosporine, the induction of c-jun mRNA at 60 min during the recovery was markedly suppressed (95 or 82% reduction, respectively). The c-jun induction was partially inhibited when the cells were treated with 2 mM EGTA during MI and the recovery (42% reduction). MAP kinase activity quantified with in-gel kinase assay was unchanged during MI, but significantly increased at 5, 10, and 15 min during the recovery (3.0-, 4.1-, and 3.4 -fold increase, respectively). S6 kinase activity was also augmented significantly at 15 min during the recovery. Thus, these data suggest that IE genes as well as MAP kinase may play roles in the recovery process of cardiac myocytes from MI, and that the augmentation of c-jun expression needs the activation of PKC and to some extent, [Ca2+]1. (J. Clin. Invest. 1995. 96:69-77.) 
Introduction
Myocardial ischemia causes a variety of damages in cardiac myocytes. These ischemic damages result in cardiac pump failure and poor prognosis in patients with ischemic heart disease. A prolonged period of ischemia induces myocardial necrosis, which may decrease the number of contracting myocytes because matured cardiac myocytes are terminally differentiated cells and cannot divide anymore. After myocardial infarction after a prolonged ischemia, a massive myocardial necrosis, and a reconstructing process called "ventricular remodeling" occurs. This ventricular remodeling may be an adaptive process to the loss of myocytes, and consists of hypertrophy of the remaining cardiocytes. On the other hand, the remodeling provokes a further ventricular dysfunction and high mortality as well as morbidity ( 1, 2) . In contrast to the prolonged ischemia, cardiac myocytes can recover from a brief period of ischemia, although persistent myocardial depression called "myocardial stunning" may follow the ischemic insults. During the recovery after the brief ischemia, cardiac myocytes adjacent to the injury show prominent nucleoli, indicating active protein synthesis (3) . Moreover, a clinical study showed that repetitive transient ischemia caused hypertrophy of cardiac myocytes in ischemic segments (4) . However, molecular mechanisms underlying these active recovery processes remain to be elucidated.
Until now, intracellular molecular mechanisms of cardiac adaptation have been examined exclusively in in vivo and in vitro hypertrophic responses. Many growth factors (5) , pressure overload (6) (7) (8) , and stretch stimulation (9) have been shown to lead myocardial hypertrophy through the activation of multiple signaling pathways proceeding to the induction of the immediate-early (IE)' genes. As to the response to growth factors, it is clear that the first event is the binding of the growth factors to their specific receptors, which was followed by the activation of various intracellular signal transduction pathways. Since it was reported that cardiac hypertrophy was induced by a I-adrenergic stimulation and associated with the expression of the cmyc gene (10) , various cellular proto-oncogenes have been reported to play roles in cardiac hypertrophy as transcriptional factors. AP-1 proteins such as c-Jun and c-Fos were reported to become homo-or hetero-dimerized to bind to the specific sequence (AP-1 site) in the enhancers of the various genes and then regulate their expression (11) (12) (13) . The genes containing an AP-1 site include cardiac genes such as skeletal a-actin ( 14) , myosin light chain (15) , atrial natriuretic peptide (16, 17) , and TGF-/3 (18) . On the other hand, in a recent study (9) using a stretch model of cultured cardiac myocytes, in which the cardiac hypertrophic responses occurred, multiple signaling pathways such as protein kinase C (PKC) cascade, tyrosine-kinase cascade, and MAP kinase cascade were shown to be activated. The expression of IE genes was also increased and then protein synthesis was accelerated. These data suggest that both the induction of IE genes and the activation of the protein kinase cascades were early intracellular events in response to growth stimuli in cardiac myocytes. In brain (19) , and kidney (20, 21) , the induction of IE genes was also documented as an early response to ischemia and/or reperfusion. In (6, 000 Ci/mM; NEN Dupont, Boston, MA). After 17 tA of incubation buffer included in the kit, 1-3 tld of the labeled AP-1 probe solution, and 5 pl of the nuclear protein solution as described above were mixed and then incubated at room temperature for 30 min, the mixtures with 2 p1 of 0.1% bromphenol blue dye were electrophoresed at 40C in 5% polyacrylamide gel. The gels were exposed to x-ray films (New RX; Fuji Film, Kanagawa, Japan) for 12-24 h and the x-ray films were developed.
MAP kinase in-gel kinase assay MAP kinase activity was measured according to the previously described method (28). Briefly, the cells at the specific time point were washed with ice-cold PBS (-) twice and harvested with a rubber policeman in 1.2 ml of MAP lysis buffer containing 25 mM Tris-HCl (pH 7.4), 25 mM NaCl, 10 mM NaF, 10 ruM Na2P207, 0.5 mM EGTA, 1 mM Na3VO4, 10 nM okadaic acid, 1 mM PMSF, 1.6 uM leupeptin, 1.5 nM aprotinin, and 38 mM p-nitrophenyl phosphate. The cell-free lysates were prepared from the cell lysates obtained. Aliquots (20 .I) of the cell-free lysates were mixed with 5 ul of Sx loading buffer, which consisted of 62.5 mM Tris HC1 (pH 6.8), 2% SDS, 1% 2-mercaptoethanol, 10% glycerol, 0.002% bromphenol blue, and were then electrophoresed in 10% SDS-polyacrylamide gels containing 0. Ci/mM; Dupont-NEN, Boston, MA), for 1 h at room temperature and the gels were washed several times in a washing solution containing 5% trichloroacetic acid and 1% Na4P2O7 until radioactivity of the solution became negligible. After the washes, the autoradiography was performed on the dried gels with intensifying screens at -800C for 24 h and the films were developed.
Western blot analysis
The cell-free lysates were prepared from the cell lysates harvested in 1.2 ml of MAP lysis buffer according to the method of MAP kinase ingel kinase assay described above. Aliquots (20 pu) of them were mixed with 5 ttl 5x loading buffer and electrophoresed in 10% SDS-PAGE.
After electrophoresis, the proteins separated in the gel were electrically transferred to a Clear Blot P membrane (ATTO Corporation, Tokyo, Japan) with semi-dry method and the blot was blocked at room temperature in TBS (pH 7.4) containing 3% ovalbumin overnight. The blot was then incubated in TBS containing 1% Triton X, 0.3% ovalbumin and 2 Ag/ml polyclonal antibodies against MAP kinase (UBI) obtained from rabbit for 1 h. After subjected to appropriate washes in TBS containing 1% Triton X and 0.3% ovalbumin, the blot was also incubated in TBS containing 1% Triton X, 0.3% ovalbumin and 1:3,000 diluted second antibodies (goat anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase provided by ECL) for 30 min. After this incubation, the blot was washed three times (30-, 15- , and lO-min), and exposed to xray films (New RX; Fuji Film, Kanagawa, Japan) by the chemiluminescence method (ECL). The x-ray films were then developed.
S6 peptide kinase assay S6 peptide kinase assay was performed with a previously described method (29) . Aliquots (100 tAl) of the cell free lysates harvested in 200 ul of MAP lysis buffer as described above were incubated with 5
Ag of polyclonal anti-rat rsk kinase antibody (UBI) for 2 h on ice.
After that, the mixture with 100 ul of 5% protein A-Sepharose was incubated for 60 min rotated at 40C and then centrifuged at 14 ,000 rpm for 15 210 Al of 25% Pluronic F127 (wt/wt in dimethyl sulfoxide), and 1 mM indo-I/AM in dimethyl sulfoxide were prepared by sonication. The loading stocks were diluted in the serumfree media up to 5 1M indo-1 /AM concentration. Cells on the coverslip in 100-mm dishes were moved in the diluted dye solution to be incubated in a 5% C02-95% air at 37TC for 15 min, and then washed in dye-free serum free medium in the same condition for 5 min. After that, the cells were placed in the flow-through chamber. While the indo-I-loaded cells were continuously superfused with media being bubbled with 5% C02-95% air and kept at 37TC, fluorescence from the cells was being measured with the previously-described system (30, 31 
Results
Expression of immediate-early gene mRNAs. Northern blot analysis and the following densitometry showed that the levels of c-jun and c-myc mRNAs remained unchanged and c-fos mRNA was not detected for 2 h during MI (Fig.1) . In contrast, significant increases in c-jun and c-myc mRNAs were observed at 30, 60, 90, and 120 min during the recovery from MI (Fig.  2 , densitometric values of c-jun mRNA were 3.0*, 4.7 *, 2.4 *, and 1.9t -fold induction compared with the control levels, respectively, and those on c-myc mRNA were 1.4*, 1.7*, 1.8*, and 2.0* -fold induction compared with the control levels, n = 3, *P < 0.01, tp < 0.05, respectively). On the other hand, Northern blot analysis demonstrated a transient induction of c-fos mRNA at 30 and 60 min during the recovery from MI (Fig. 2) Fig. 3, b) . We then examined the induction of c-jun mRNA at 60 min during the recovery phase. With 2 mM EGTA, the levels of c-jun mRNA at 60 min during the recovery phase were significantly reduced as compared with those without EGTA (42% reduction, n = 3, P < 0.01; Fig. 4 Effects of PKC, PKA, and calmodulin kinase on the induction of c-jun mRNA. After the pretreatment of 100 uM H-7 or 1 uM staurosporine, the induction of c-jun mRNA during the recovery was markedly suppressed in the presence of 100 yM H-7 (95% reduction of the levels without H-7 at 60 min during the recovery, n = 3, P < 0.01, Fig. 5 ) or 1 ILM staurosporine (82% reduction of the levels without staurosporine at 60 rin during the recovery, n = 3, P < 0.01; Fig. 6 .). These data suggest that an activation of PKC may be essential for the cjun induction during the recovery phase after MI. In contrast, the similar treatment of either 10 pM H-89 or 10 ,M W-7 did not influence significantly the expression of c-jun mRNA at 60 min during the recovery from MI (Fig. 6) . The binding activity in the AP-J element. EMSA with the 32P-labeled oligonucleotide containing the AP-1 element revealed that a single retarded band was observed in all the lanes except the left end lane in Fig. 7 a. Intensity of the band, representing the DNA binding activity of the nuclear proteins, markedly increased at 120 min during the recovery from MI (Fig. 7 a) . As shown in Fig. 7 b, cold AP-l probes, but not in the presence of other cold probes including AP-2, AP-3, SPI, and NFl/CTF. MAP kinase isoform expressed in chicken hearts. Western blot analysis with anti-MAP kinase antibodies showed that isoforms of MAP kinase mainly consisted of 42-kD MAP kinase (Fig. 8 a) , as reported in a recent study (36) .
MAP kinase activity. The mobility shift assay of MAP ki- nase with anti-MAP kinase antibody (Fig. 8 a) showed that mobility shifts of the MAP kinase protein were transiently observed from 5 to 15 min during the recover from MI. In-gel kinase assay of the samples from the same series (Fig. 8 a, S6 peptide kinase activity. As shown in Fig. 9 ., S6 kinase, pRSK90, was significantly activated at 15 min during the recovery from MI (2.1+0.4-fold increase as compared with the control levels, n = 4, P < 0.05).
Discussion
The present study has revealed that both the expression of E gene mRNAs and the activity of MAP kinase were augmented, not during MI, but during the recovery from MI. The induction of c-jun mRNA was shown to depend on the activation of PKC, and to some extent, on intracellular Ca2+. The (17) . Although which cardiac or TE genes are directly activated by c-jun or c-fos product remains to be clarified, the induction of these mRNA species seems to be one of the first among the serial gene activation during the recovery phase after MI. To further investigate the role of AP-l proteins in the recovery process after MI, CAT assay of certain cardiac or LE gene will be needed both during and after MI. Our study has demonstrated that MAP kinase activity was also augmented only during the recovery from MI. In other types of cultured cells, MAP kinase was generally considered to mediate proliferation and microtubulus stability in M phase (29, 35) . However, in cardiac myocytes that lost the ability to proliferate, the role of MAP kinase in their function remained uncertain. A recent in vitro study (29) suggested that MAP kinase seemed to play an important role in myocardial hypertrophic processes, probably by accelerating protein synthesis and regulating the function of the transcriptional factors. Thus, the increase in MAP kinase activity might have a supportive effect on the repair and reproduction of cellular components by activating S6 kinase, which is suggested to accelerate the protein synthesis. In fact, we observed an increase in S6 kinase activity during the recovery from MI in the present study. Moreover, MAP kinase is known to positively regulate the activity of the specific promotor regions such as AP-1 site and serum response element by phosphorylating c-Jun (39) and Elk-1 (40) (45) previously reported that this cell culture contained negligible amounts of nonmyocytes, and we can therefore neglect the effects of the contaminating cells. Third, in cultured cells, the effect of mechanical stress may be negligible. On the other hand, limitations of the present study may also be related to the use of this "in vitro" model. This kind of "in vitro" cell culture model usually represents only a partial aspect of "in vivo" pathophysiological processes. We believe, however, that our results can be reasonably extended to "in vivo" ischemia, because our "in vitro" model represents one of the most essential aspects of ischemia, that is, energy depletion.
We conclude that in cardiac myocytes the induction of IE genes and MAP kinase activation seem to play roles in the recovery of cardiac myocytes from a brief period of MI. Our "in vitro" model of metabolic inhibition/recovery will be feasible for more detailed study of molecular mechanisms underlying ischemia/reperfusion process.
